The company expired its plan on June 21, 2023.
Lansen Pharmaceutical Holdings Limited
Equities
503
KYG5380M1033
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+30.95% | 695B | |
+26.51% | 568B | |
-4.65% | 361B | |
+19.51% | 330B | |
+3.89% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+8.44% | 168B |